Why Methylene Blue Have to Be Always Present in the Stocking of Emergency Antidotes

Author(s): Caroline F. Baldo, Luiza M. Silva, Livia Arcencio, Agnes A.S. Albuquerque, Andrea C. Celotto, Anibal Basile-Filho, Paulo R.B. Evora*

Journal Name: Current Drug Targets

Volume 19 , Issue 13 , 2018

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Evidence-based review of the existing literature ultimately recommends stocking of Methylene Blue (MB) as an emergency antidote in the United States. The same is reported around the world in Japan, Greece, Italy and Canada. The observation that MB is always present as the main antidote required in emergency and critical care units calls for a revisit on its effects on the NO/cGMP system to reemphasize its multisystem actions. Therefore, the present review aimed to display the role of MB in emergency units, concerning: 1) Polytrauma and circulatory shock; 2) Neuroprotection, 3) Anaphylaxis and, 4) Overdose and poisoning.

Keywords: Methylene blue, cGMP, nitric oxide, circulatory shock, neuroprotection, anaphylaxis, poisoning.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Published on: 12 September, 2018
Page: [1550 - 1559]
Pages: 10
DOI: 10.2174/1389450119666180403100410
Price: $65

Article Metrics

PDF: 43